IMA vs LI · rev $9.2M vs P/E 24, rev $16.06B
ImageneBio, Inc. (IMA) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
IMA currently screens at market cap $64.7M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the IMA and LI stock pages for the full models.
Not investment advice.